Novavax Profit And Partnership Pivot Reframe Risk And Valuation Story [Yahoo! Finance]
Novavax, Inc. (NVAX)
Last novavax, inc. earnings: 3/11 04:17 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.novavax.com/investor-relations
Company Research
Source: Yahoo! Finance
Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Novavax (NasdaqGS:NVAX) reported a surprise profit for the fourth quarter, alongside revenue that was above prior expectations. The company is shifting its business model by transferring commercialization of its COVID-19 vaccine Nuvaxovid to Sanofi. Novavax plans to focus on a partnership-driven approach centered on milestone payments, royalties, and advancing its pipeline. For you as an investor, the key change is that Novavax is moving away from directly commercializing Nuvaxovid and placing greater emphasis on partners such as Sanofi. Novavax remains a vaccine-focused biotechnology company, and this model can place more attention on research, development, and collaborations rather than maintaining a full commercial infrastructure on its own. The combination of a profitable quarter and a pivot toward partner-based revenue streams mark
Show less
Read more
Impact Snapshot
Event Time:
NVAX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVAX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVAX alerts
High impacting Novavax, Inc. news events
Weekly update
A roundup of the hottest topics
NVAX
News
- Is Trending Stock Novavax, Inc. (NVAX) a Buy Now? [Yahoo! Finance]Yahoo! Finance
- Novavax, Inc. (NVAX) Presents at TD Cowen 46th Annual Health Care Conference Transcript [Seeking Alpha]Seeking Alpha
- How The Novavax (NVAX) Story Is Shifting Toward Licensing Income And COVID Recalibration [Yahoo! Finance]Yahoo! Finance
- Why Novavax (NVAX) Shares Are Falling Today [Yahoo! Finance]Yahoo! Finance
- Novavax (NVAX) had its price target raised by HC Wainwright from $11.00 to $16.00. They now have a "buy" rating on the stock.MarketBeat
NVAX
Earnings
- 2/26/26 - Beat
NVAX
Sec Filings
- 3/5/26 - Form 4
- 3/5/26 - Form 4
- 3/5/26 - Form 4
- NVAX's page on the SEC website